Study finds a common bacterium can suppress the body’s early warning system in wounds, causing infections to persist and create an environment that allows other bacteria to take hold.
A new biohybrid system developed at MIT is the first living implant that uses rewired nerves to revive paralyzed organs.
The cells can survive in the body for at least three months, producing enough insulin to control blood sugar levels, research shows.
A backup survival pathway can help tumor cells resist certain lung cancer and other drugs. Combining therapies may offer a solution.
As an aspiring physician-scientist and editor-in-chief of The Tech, MIT senior Alex Tang has found inspiration in the lives of patients and others in his community.
An MIT-led team is designing artificial intelligence systems for medical diagnosis that are more collaborative and forthcoming about uncertainty.
Anthropologist Amy Moran-Thomas studies overlooked insights from people health care is meant to reach.
SMART breakthrough offers a promising pathway toward improved manufacturing of high‑quality cells for regenerative therapies to treat joint diseases.
MIT senior Srihitha Dasari reflects on the power of experiential learning through the PKG Center for Social Impact.
The technology could enable fast, point-of-care diagnoses for pneumonia and other lung conditions.
By showing the problem derives from genetic mutations that lead to overexpression of a microRNA, MIT researchers’ study points to potential treatment.
Researchers at MIT, Mass General Brigham, and Harvard Medical School developed a deep-learning model to forecast a patient’s heart failure prognosis up to a year in advance.
Assistant Professor Matthew Jones is working to decode molecular processes on the genetic, epigenetic, and microenvironment levels to anticipate how and when tumors evolve to resist treatment.
From early motion-sensing platforms to environmental monitoring, the professor and head of the Program in Media Arts and Sciences has turned decades of cross-disciplinary research into real-world impact.
The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure.